Skip to content

Schering-Plough SGP Retained Earnings

Retained Earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$169.16B+4.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$36.42B+12.5%
Glaukos logo
GlaukosGKOS
-$952.91M-24.8%
AbbVie logo
AbbVieABBV
-$17.87B-87.6%
Bausch + Lomb logo
Bausch + LombBLCO
-$1B-28.0%
HRO
HarrowHROW
-$184.13M-8.8%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's retained earnings?
Schering-Plough (SGP) reported retained earnings of -$118.55M in Q1 2026.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.